Previous 10 | Next 10 |
Luminex Corporation (LMNX) announces Q3 revenues of ~$106M (+35% y/y) vs. a consensus of $105M.Molecular Diagnostics revenue was up ~100% y/y to ~$60M, Licensed Technologies revenue decreased ~10% to ~$35M and Flow Cytometry revenue was up ~13% to $10M.The company to release results on Nov. 2...
ABT is securing more orders for millions of its rapid covid-19 testing kits. While the medical devices segment was hit hard with double-digit declines in organic growth, trends in procedure volume show a path to recovery. Relative to other players in the rapid testing space, ABT h...
Luminex (LMNX) receives ~$5.4M award from the Biomedical Advanced Research and Development Authority or BARDA to conduct product development work and complete filing for Luminex's expanded NxTAG Respiratory Pathogen Panel.This includes the SARS-CoV-2 virus for high-throughput C...
Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2 High-throughput diagnostic test will include most up-to-date respiratory pathogen targets PR Newswire AUSTIN, Texas, Sept. 24, 2020 AUSTIN, Texas...
The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority ((BARDA)) has awarded $683,500 to Luminex (LMNX) to support the enhancement of its xMAP SARS-CoV-2 Multi-Antigen IgG Assay which detects antibodies to three antigens of the coronavirus.The...
Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test Project will expand utility of xMAP SARS-CoV-2 Multi-Antigen IgG Assay to better indicate whether individuals are protected against future infection PR Newswire AUSTIN, Texas, Sept. 2...
Investment Thesis Enzo Biochem, Inc. ( ENZ ) is a vertically integrated life sciences company focusing on developing unique diagnostic platform technologies. Specific to the outbreak of COVID-19, ENZ also provides both molecular and serology tests in New York, New Jersey, and Connecticut. ...
Several stocks of companies that make COVID-19 diagnostic tests were sinking on Thursday following big news from Abbott Laboratories (NYSE: ABT) on Wednesday evening. Abbott announced that it received FDA emergency use authorization (EUA) for a COVID-19 antibody test that costs $5 and provi...
Image source: The Motley Fool. Luminex Corp (DE) (NASDAQ: LMNX) Q2 2020 Earnings Call Aug 4, 2020 , 5:00 p.m. ET Operator Continue reading
Luminex Corporation (LMNX) Q2 2020 Earnings Conference Call August 4, 2020 05:00 PM ET Company Participants Harriss Currie - Senior Vice President and Chief Financial Officer Nachum Shamir - President and Chief Executive Officer Conference Call Participants Andrew Brackmann -...
News, Short Squeeze, Breakout and More Instantly...
Middlesex Water Set to Join S&P SmallCap 600 Middlesex Water Set to Join S&P SmallCap 600 PR Newswire NEW YORK , July 12, 2021 /PRNewswire/ -- Middlesex Water Co. (NASD: MSEX) will replace Luminex Corp. (NASD: LMNX) in the S&P SmallCap 600 ef...
NEW YORK, NY / ACCESSWIRE / May 12, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York ...
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion IMPORTANT NOTICE By reading the following release, you further agree to be bound by the following limitations and qualifications: This communication is for informational purp...